OPGEN INC (OPGN)

US68373L4068 - Common Stock

0.47  -0.02 (-3.09%)

After market: 0.48 +0.01 (+2.13%)

News Image
3 days ago - Chartmill

What's going on in today's session

Wondering how the US markets performed one hour before the close of the markets on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.

News Image
4 days ago - OpGen, Inc.

OpGen Provides Update on Business Operations and Strategic Opportunities

ROCKVILLE, Md., April 29, 2024 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”) announced today that it entered into an agreement...

News Image
10 days ago - OpGen, Inc.

OpGen Receives Nasdaq Notice Regarding Delayed Form 10-K

ROCKVILLE, Md., April 23, 2024 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”) announced today that it received a notice from...

News Image
a month ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

It's time to dive into the biggest pre-market stock movers on Tuesday as we check out all of the hottest news moving shares this morning!

News Image
a month ago - OpGen, Inc.

OpGen Announces Acquisition of Preferred Stock by David Lazar

David Lazar invests $3 million in Preferred StockNew OpGen Board of Directors appointedDavid Lazar will take over as CEO of OpGenOpGen settles outstanding...

News Image
6 months ago - OpGen, Inc.

OpGen Reports Third Quarter 2023 Financial Results and Provides Business Update

Total revenue for the first nine months of 2023 was approximately $2.35 million compared to approximately $1.89 million in the first nine months of...

News Image
6 months ago - Seeking Alpha

OpGen files to sell 10.89M shares to holders (NASDAQ:OPGN)

OpGen (OPGN) files prospectus for the resale of 10.89M common shares by selling stockholders.

News Image
7 months ago - OpGen, Inc.

OpGen Enters Into Warrant Inducement Transaction for up to $11.2 Million in Gross Proceeds

ROCKVILLE, Md., Oct. 12, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”), a precision medicine company harnessing the...